Clinical evaluation of two consanguineous families with homozygous mutations in BEST1
(2011) In Molecular Vision 17(179). p.1607-1617- Abstract
- Purpose: To describe the clinical and genetic findings in two consanguineous families with Best vitelliform macular dystrophy (BVMD) and homozygous mutations in the bestrophin-1 (BEST1) gene. Methods: Ophthalmologic examination was performed in eight members of two families originating from Spain and Denmark. Mutation screening was performed using the Vitelliform Macular Dystrophy mutation array from Asper Biotech, and by the directed genomic sequencing of BEST1. Results: Two homozygous mutations were detected in these families. Mutation c.936C>A (p.Asp312Glu) has been reported previously in a Danish family; here, we describe four additional individuals in this family demonstrating findings compatible with a severe dominant BVMD, albeit... (More)
- Purpose: To describe the clinical and genetic findings in two consanguineous families with Best vitelliform macular dystrophy (BVMD) and homozygous mutations in the bestrophin-1 (BEST1) gene. Methods: Ophthalmologic examination was performed in eight members of two families originating from Spain and Denmark. Mutation screening was performed using the Vitelliform Macular Dystrophy mutation array from Asper Biotech, and by the directed genomic sequencing of BEST1. Results: Two homozygous mutations were detected in these families. Mutation c.936C>A (p.Asp312Glu) has been reported previously in a Danish family; here, we describe four additional individuals in this family demonstrating findings compatible with a severe dominant BVMD, albeit with reduced penetrance in heterozygotes. In the Spanish family, a novel homozygous missense mutation in exon 4, c. 388 C>A (p.Arg130Ser), was identified in the siblings. Homozygous siblings demonstrated evidence of multifocal vitelliform retinopathy, whereas heterozygous family members presented findings ranging from isolated reduction of the electrooculogram Arden ratio to normal values on all clinical parameters. Conclusions: As demonstrated in these consanguineous families, a great clinical variability is associated with homozygous mutations in BEST1, ranging from severe dominant BVMD with reduced penetrance in heterozygotes to autosomal recessive bestrophinopathy. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/2042219
- author
- Pineiro-Gallego, Teresa ; Alvarez, Maria ; Pereiro, Ines ; Campos, Severiano ; Sharon, Dror ; Schatz, Patrik LU and Valverde, Diana
- organization
- publishing date
- 2011
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Molecular Vision
- volume
- 17
- issue
- 179
- pages
- 1607 - 1617
- publisher
- Molecular Vision
- external identifiers
-
- wos:000292054400001
- scopus:79959937313
- ISSN
- 1090-0535
- language
- English
- LU publication?
- yes
- id
- 683fdfb7-0f20-4e80-80e6-c703f8df7080 (old id 2042219)
- alternative location
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123162/
- date added to LUP
- 2016-04-01 13:02:22
- date last changed
- 2022-01-27 08:57:11
@article{683fdfb7-0f20-4e80-80e6-c703f8df7080, abstract = {{Purpose: To describe the clinical and genetic findings in two consanguineous families with Best vitelliform macular dystrophy (BVMD) and homozygous mutations in the bestrophin-1 (BEST1) gene. Methods: Ophthalmologic examination was performed in eight members of two families originating from Spain and Denmark. Mutation screening was performed using the Vitelliform Macular Dystrophy mutation array from Asper Biotech, and by the directed genomic sequencing of BEST1. Results: Two homozygous mutations were detected in these families. Mutation c.936C>A (p.Asp312Glu) has been reported previously in a Danish family; here, we describe four additional individuals in this family demonstrating findings compatible with a severe dominant BVMD, albeit with reduced penetrance in heterozygotes. In the Spanish family, a novel homozygous missense mutation in exon 4, c. 388 C>A (p.Arg130Ser), was identified in the siblings. Homozygous siblings demonstrated evidence of multifocal vitelliform retinopathy, whereas heterozygous family members presented findings ranging from isolated reduction of the electrooculogram Arden ratio to normal values on all clinical parameters. Conclusions: As demonstrated in these consanguineous families, a great clinical variability is associated with homozygous mutations in BEST1, ranging from severe dominant BVMD with reduced penetrance in heterozygotes to autosomal recessive bestrophinopathy.}}, author = {{Pineiro-Gallego, Teresa and Alvarez, Maria and Pereiro, Ines and Campos, Severiano and Sharon, Dror and Schatz, Patrik and Valverde, Diana}}, issn = {{1090-0535}}, language = {{eng}}, number = {{179}}, pages = {{1607--1617}}, publisher = {{Molecular Vision}}, series = {{Molecular Vision}}, title = {{Clinical evaluation of two consanguineous families with homozygous mutations in BEST1}}, url = {{http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123162/}}, volume = {{17}}, year = {{2011}}, }